Clinical Trial Update: Doxorubicin Hydrochloride Liposome and Carboplatin in Treating Patients With Recurrent, Stage III, or Stage IV Primary Endometrial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating doxorubicin hydrochloride liposome plus carboplatin for recurrent, stage III or IV endometrial cancer was terminated; results have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOXORUBICIN HYDROCHLORIDE LIPOSOME (DOXORUBICIN HYDROCHLORIDE)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Endometrial Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-08-22